BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1929 related articles for article (PubMed ID: 18227481)

  • 1. NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities.
    Paravicini TM; Touyz RM
    Diabetes Care; 2008 Feb; 31 Suppl 2():S170-80. PubMed ID: 18227481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanisms of hypertension--reactive oxygen species and antioxidants: a basic science update for the clinician.
    Montezano AC; Touyz RM
    Can J Cardiol; 2012 May; 28(3):288-95. PubMed ID: 22445098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactive oxygen species and vascular biology: implications in human hypertension.
    Touyz RM; Briones AM
    Hypertens Res; 2011 Jan; 34(1):5-14. PubMed ID: 20981034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanisms of hypertension: role of Nox family NADPH oxidases.
    Sedeek M; Hébert RL; Kennedy CR; Burns KD; Touyz RM
    Curr Opin Nephrol Hypertens; 2009 Mar; 18(2):122-7. PubMed ID: 19430333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular NADPH oxidases as drug targets for novel antioxidant strategies.
    Guzik TJ; Harrison DG
    Drug Discov Today; 2006 Jun; 11(11-12):524-33. PubMed ID: 16713904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Redox signaling in hypertension.
    Paravicini TM; Touyz RM
    Cardiovasc Res; 2006 Jul; 71(2):247-58. PubMed ID: 16765337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactive oxygen species and endothelial function--role of nitric oxide synthase uncoupling and Nox family nicotinamide adenine dinucleotide phosphate oxidases.
    Montezano AC; Touyz RM
    Basic Clin Pharmacol Toxicol; 2012 Jan; 110(1):87-94. PubMed ID: 21883939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting reactive oxygen species in hypertension.
    Cifuentes ME; Pagano PJ
    Curr Opin Nephrol Hypertens; 2006 Mar; 15(2):179-86. PubMed ID: 16481886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NAD(P)H oxidase and endothelial dysfunction.
    Muller G; Morawietz H
    Horm Metab Res; 2009 Feb; 41(2):152-8. PubMed ID: 18816427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative stress, Noxs, and hypertension: experimental evidence and clinical controversies.
    Montezano AC; Touyz RM
    Ann Med; 2012 Jun; 44 Suppl 1():S2-16. PubMed ID: 22713144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidative stress and vascular remodelling.
    Fortuño A; San José G; Moreno MU; Díez J; Zalba G
    Exp Physiol; 2005 Jul; 90(4):457-62. PubMed ID: 15890797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases.
    Cai H; Griendling KK; Harrison DG
    Trends Pharmacol Sci; 2003 Sep; 24(9):471-8. PubMed ID: 12967772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The molecular sources of reactive oxygen species in hypertension.
    Puddu P; Puddu GM; Cravero E; Rosati M; Muscari A
    Blood Press; 2008; 17(2):70-7. PubMed ID: 18568695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NAD(P)H oxidase and uncoupled nitric oxide synthase are major sources of glomerular superoxide in rats with experimental diabetic nephropathy.
    Satoh M; Fujimoto S; Haruna Y; Arakawa S; Horike H; Komai N; Sasaki T; Tsujioka K; Makino H; Kashihara N
    Am J Physiol Renal Physiol; 2005 Jun; 288(6):F1144-52. PubMed ID: 15687247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is mycophenolate more than just an immunosuppressant?--An overview.
    Iyer A; Brown L
    Indian J Biochem Biophys; 2009 Feb; 46(1):25-30. PubMed ID: 19374250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of arteries and veins in oxidative stress: producers, destroyers, function, and disease.
    Szasz T; Thakali K; Fink GD; Watts SW
    Exp Biol Med (Maywood); 2007 Jan; 232(1):27-37. PubMed ID: 17202583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NADPH oxidase-derived reactive oxygen species: involvement in vascular physiology and pathology.
    Manea A
    Cell Tissue Res; 2010 Dec; 342(3):325-39. PubMed ID: 21052718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular NAD(P)H oxidase activation in diabetes: a double-edged sword in redox signalling.
    Gao L; Mann GE
    Cardiovasc Res; 2009 Apr; 82(1):9-20. PubMed ID: 19179352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial dysfunction and reactive oxygen species production in ischemia/reperfusion and nitrate tolerance.
    Szocs K
    Gen Physiol Biophys; 2004 Sep; 23(3):265-95. PubMed ID: 15638116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential vascular functions of Nox family NADPH oxidases.
    Brandes RP; Schröder K
    Curr Opin Lipidol; 2008 Oct; 19(5):513-8. PubMed ID: 18769233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 97.